We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
+38.74%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$355M
AUM Growth
+$37.9M
Cap. Flow
-$69.5M
Cap. Flow %
-19.56%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
NVAX icon
Novavax
NVAX
+$8.14M
2
XLRN
Acceleron Pharma
XLRN
+$1.11M

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$78.7M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
1
10x Genomics
TXG
$5.55B
$343M 96.54%
2,750,000
-750,000
-21% -$78.7M
NVAX icon
2
Novavax
NVAX
$1.35B
$7.24M 2.04%
+66,810
New +$8.14M
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$2.91M 0.82%
243,759
– –
XLRN
4
DELISTED
Acceleron Pharma
XLRN
$2.15M 0.61%
19,100
+11,100
+139% +$1.11M

Similar funds

A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
AGDR
AdamCapital Gestao de Recursos Rio De Janeiro, Brazil $18.1M AUM 32.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
WL
WiL LLC Palo Alto, California $17.5M AUM 75.04% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
SVGI
Sozo Ventures GP I Redwood City, California $16.3M AUM 66.18% 1-Year Est. Return

Foresite Capital Management I's Q3 2020 Portfolio in Review

As of Q3 2020, Foresite Capital Management I held 4 positions worth $355M, up 12% from $317M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management I withdrew a net $69.5M in Q3 2020, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $78.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Foresite Capital Management I opened a new position in Novavax worth $7.24M.

  • Foresite Capital Management I's largest Q3 2020 buy was Novavax: 66,810 shares worth $7.24M.
  • Foresite Capital Management I added most to Acceleron Pharma in Q3 2020, an estimated $1.11M increase.
  • Foresite Capital Management I's biggest Q3 2020 reduction was 10x Genomics, cutting an estimated $78.7M.
  • Foresite Capital Management I's ten largest holdings make up 100% of its $355M portfolio in Q3 2020.
  • Foresite Capital Management I opened 1 new position and closed 0 in Q3 2020.
  • Foresite Capital Management I's portfolio value rose 12% quarter-over-quarter to $355M.

Based on Foresite Capital Management I's 13F filing for Q3 2020, filed 13 Nov 2020.